Penn Board of Trustees votes to appoint J. Larry Jameson President and extend his term through June 2027
Jameson has served as Interim President since December 2023. Prior to that, he was Executive Vice President of the University of Pennsylvania for the Health System and Dean of the Raymond and Ruth Perelman School of Medicine.
“I am confident that our University’s future is bright as we prioritize our core values of excellence, freedom of inquiry and expression, and respect,” says Penn President J. Larry Jameson. “I am deeply committed to this extraordinary institution, and it is an honor to serve as Penn’s President.”
The Board of Trustees of the University of Pennsylvania today voted unanimously to appoint J. Larry Jameson, who has served as Interim President since December 2023, President of the University for a term that will run through June 30, 2027.
In announcing the appointment, Chair of the Board of Trustees Ramanan Raghavendran stated, “The challenges facing higher education today are among the most significant ever encountered by American universities. Given Penn’s complexity, size, location, and visibility, these issues have profound implications for our community.”
“In such a moment, there is nothing more important than leadership.”
“Penn has been very fortunate to have Larry Jameson at the helm during this time. I am pleased that our Board can recognize his exceptional performance, and acknowledge his inspirational leadership and vision, by formally extending his appointment to June 30, 2027.”
In accepting the Board’s appointment, Jameson stated, “I am profoundly honored by this vote of confidence from our Board of Trustees. I look forward to continuing the vital work of our faculty, staff, students, alumni, and community members to uphold Penn’s mission of utilizing knowledge for the greater good. I am confident that our University’s future is bright as we prioritize our core values of excellence, freedom of inquiry and expression, and respect. I am deeply committed to this extraordinary institution, and it is an honor to serve as Penn’s President.”
Before joining Penn Medicine, Jameson served for four years as Dean of the Feinberg School of Medicine and Vice President of Medical Affairs at Northwestern University. He first joined Northwestern University Medical School in 1993, as chief of the Division of Endocrinology, Metabolism, and Molecular Medicine. In 2000, he was named Irving S. Cutter Professor of Medicine and chair of the Department of Medicine.
Jameson received his medical degree with honors and a doctoral degree in biochemistry from the University of North Carolina in 1981. He completed clinical training in internal medicine and endocrinology at the Massachusetts General Hospital in Boston. Before leaving for Northwestern University, he rose through the ranks at Harvard Medical School to become an associate professor of medicine and chief of the Thyroid Unit at Massachusetts General Hospital.
An accomplished physician-scientist, Jameson has pioneered studies of the genetic basis of hormonal disorders, and he is the author of more than 350 scientific articles and chapters. He is an editor of “Harrison’s Principles of Internal Medicine,” the most widely used textbook of internal medicine. His research has been published in leading peer-reviewed journals, including The New England Journal of Medicine, Nature Genetics, Science, and the Journal of Clinical Investigation. He has served as President of The Endocrine Society and Association of American Physicians, and recently chaired the Board of Directors of the American Association of Medical Colleges. Jameson has received many distinguished awards, including the Van Meter Award from the American Thyroid Association, the Koch Award from The Endocrine Society, and the Sheen Award from the American College of Surgeons. Jameson is a member of the American Academy of Arts and Sciences and the National Academy of Medicine.
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
